Objective: Intracellular signaling of activin and transforming growth factor-b (TGF-b) is thought to be mediated by the same molecules (Smad2/3 and Smad4). Although differentiation of murine erythroleukemia F5-5.fl cells is induced by activin, it is not induced by TGF-b, suggesting that at some point TGF-b signaling is defective. The aim of this study was to investigate the unresponsiveness of An erythrodifferentiation assay using F5-5.fl cells would be useful for measuring net activin activity because it would not be necessary to consider endogenous activins and BMPs.
Introduction
Activins, transforming growth factor (TGF)-bs and bone morphogenetic proteins (BMPs) are members of the TGF-b superfamily. They are involved in diverse physiological processes, and are believed to act as regulators of cell growth and differentiation (1±4). The TGF-b family members initiate their cellular action by binding to receptor serine kinases consisting of two subfamilies, type I and type II receptors. Each member of the TGF-b family binds to a characteristic combination of type I and type II receptors, both of which are needed for signaling (5, 6) . During the past 5 years, Smad proteins have been identified as signal mediators of the TGF-b family members, whereby Smad2 and Smad3 are pathway-restricted Smads for both activin and TGF-b signaling, whereas Smad1, Smad5 and Smad8 are for BMP signaling (5) . Upon phosphorylation of the carboxyl-terminal serines in pathway-restricted Smads, they form complexes with common Smad (Smad4), followed by nuclear translocation and transcriptional regulation of the target gene (5) .
Both activin and TGF-b are reported to have roles in the regulation of erythropoiesis (7±10). Activin A and TGF-b1 induce erythrodifferentiation in the erythroleukemic cell line, K562 cells, with similar efficiencies (11) . However, in another erythroleukemic cell line, F5-5.fl cells, although erythrodifferentiation is induced by activin A, it is not induced by TGF-b1, suggesting defective TGF-b signaling (10) .
To explore why F5-5.fl cells do not differentiate into erythroid in response to TGF-b1, we examined mRNA expression of ligands, receptors and signal mediators for the TGF-b family in F5-5.fl cells. We demonstrate that a deficiency in the type II receptor for TGF-b may be responsible for the lack of TGF-b-induced differentiation in F5-5.fl cells.
Materials and methods

Reagents
RPMI 1640 medium supplemented with 2 mmol/l glutamine was purchased from Iwaki Glass (Chiba, Japan). Fetal bovine serum (FBS) was purchased from Cansera International (Ontario, Canada). Recombinant human activin A was provided by the National Hormone and Pituitary Program (Rockville, MD, USA). Recombinant human TGF-b1 was obtained from Pepro Tech EC (London, UK). Recombinant human BMP-4 was purchased from R & D Systems (Minneapolis, MN, USA). (Fig. 1B) , and these ligands did not affect activin-stimulated erythrodifferentiation (Fig. 1C) . Fig. 2A and C) . We next analyzed the expression of mRNA coding six type I and four type II receptors for the TGF-b family in F5-5.fl cells (Fig. 3) . RT-PCR of F5-5.fl RNA yielded two type I receptor PCR products (ALK-4 (ActRIB) and ALK-5 (TbRI)), while the other four cDNAs (ALK-1, ALK-2, ALK-3 and ALK-6) were not detected (Fig. 3A) . For the type II receptors, ActRII and BMPRII cDNAs were yielded, whereas ActRIIB and TbRII cDNAs were not detected by RT-PCR of F5-5.fl cells (Fig. 3B) . The mRNA expression of Smads in F5-5.fl cells suggests that all Smad products examined in this study were expressed, although the Smad1 signal was slightly weak (Fig. 4) .
Results
Effect of activin
Discussion
In the present study, we first confirmed that activin induced erythrodifferentiation of the erythroleukemic cell line, F5-5.fl cells. Activin A, but not TGF-b1, stimulated hemoglobin production in F5-5.fl cells in a dose-dependent manner, which was consistent with a previous study (10) . In addition, BMP-4 had no direct effect on the differentiation of F5-5.fl cells, and neither TGF-b1 nor BMP-4 affected activin-induced erythrodifferentiation. Furthermore, incubation with 100 U/ ml of IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-12 or IFN-g did not change basal or activin A-induced erythrodifferentiation (data not shown). These findings suggest that measuring erythrodifferentiation of F5-5.fl cells is a useful bioassay to quantify activin activity. Another erythroleukemic cell line, K562 cells, also differentiates into hemoglobin-positive cells in response to activin. However, these cells also respond to TGF-b1 (11) . Therefore, F5-5.fl cells are more suitable for measuring activin activity than K562 cells.
Analyses of the expression of the TGF-b family ligands in F5-5.fl cells detected mRNA of TGF-bs (TGFb1, TGF-b2 and TGF-b3), whereas the expression of inhibin/activin subunits (a, bA and bB) and BMPs (BMP-2, BMP-4 and BMP-7) was not detected. The results suggest that neither activins nor BMPs were produced in F5-5.fl cells. Thus, use of F5-5.fl cells to measure activin activity has another merit in that it would not be necessary to consider endogenous activins and BMPs.
For signaling of the TGF-b family members, an appropriate combination of type I and type II receptors is needed (6) . Each member of the TGF-b family binds to a characteristic combination of type I and type II receptors (Table 2 ) (5). mRNA expression of receptors for the TGF-b family members in F5-5.fl cells is summarized in Table 3 . The results revealed the expression of both type I receptor (ALK-4/ActRIB) and type II receptor (ActRII) for activin. Furthermore, mRNAs of the Smads responsible for activin signaling (5), Smad2/3 and Smad4, were also detected in F5-5.fl cells. Expression of all the molecules involved in activin signaling may have been responsible for the sensitivity to activin in the differentiation of F5-5.fl cells. In contrast, although expression of the type I receptor for TGF-b (ALK-5/TbRI) was detected, that of the type II receptor (TbRII) was not detected in F5-5.fl cells. Since downstream signaling of activin and TGF-b is thought to be mediated by the same molecules (5), the inability of TGF-b1 to stimulate differentiation of F5-5.fl cells may be attributed to the lack of TbRII expression.
